Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | TCM_Taiwan* | |||
NPO29804 | Nepalese propolis | NA | NA | NA |
PMID[15974608] |
|||
NPO1087 | Pterocarpus santalinus | Species | Fabaceae | Eukaryota | heartwood |
PMID[21784631] |
||
NPO29581 | Dalbergiae odoriferae lignum | NA | NA | NA | TCMSP* | |||
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | IC50 | = | 15400 | nM | 15974608 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 3539.7 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 10 | ug/ml | 21784631 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | > | 10 | ug/ml | 21784631 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 35330 | nM | 21784631 |
NPT2 | Others | Unspecified | IC50 | = | 32210 | nM | 21784631 | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4610.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4109.5 | nM | PubChem BioAssay data set | ||
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 91.48 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 120.86 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 19952.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC183655 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC287395 |
0.979 | High Similarity | NPC102003 |
0.979 | High Similarity | NPC92722 |
0.9724 | High Similarity | NPC291802 |
0.9724 | High Similarity | NPC131266 |
0.9724 | High Similarity | NPC100971 |
0.9724 | High Similarity | NPC35763 |
0.9724 | High Similarity | NPC100263 |
0.9724 | High Similarity | NPC121522 |
0.9724 | High Similarity | NPC181209 |
0.9724 | High Similarity | NPC209487 |
0.9724 | High Similarity | NPC269451 |
0.9724 | High Similarity | NPC245382 |
0.9724 | High Similarity | NPC216769 |
0.972 | High Similarity | NPC15329 |
0.972 | High Similarity | NPC131451 |
0.9658 | High Similarity | NPC88645 |
0.9658 | High Similarity | NPC124714 |
0.9658 | High Similarity | NPC206238 |
0.9658 | High Similarity | NPC167091 |
0.9658 | High Similarity | NPC292214 |
0.9658 | High Similarity | NPC271779 |
0.9655 | High Similarity | NPC45291 |
0.9655 | High Similarity | NPC19980 |
0.965 | High Similarity | NPC93034 |
0.965 | High Similarity | NPC119660 |
0.9645 | High Similarity | NPC287722 |
0.9592 | High Similarity | NPC39184 |
0.9589 | High Similarity | NPC161277 |
0.9589 | High Similarity | NPC101996 |
0.9589 | High Similarity | NPC199100 |
0.9589 | High Similarity | NPC120537 |
0.9589 | High Similarity | NPC39007 |
0.9589 | High Similarity | NPC180234 |
0.9586 | High Similarity | NPC156953 |
0.9586 | High Similarity | NPC10467 |
0.9583 | High Similarity | NPC218490 |
0.958 | High Similarity | NPC143903 |
0.958 | High Similarity | NPC165389 |
0.958 | High Similarity | NPC226987 |
0.9577 | High Similarity | NPC142165 |
0.9524 | High Similarity | NPC250557 |
0.9521 | High Similarity | NPC171010 |
0.9521 | High Similarity | NPC149614 |
0.9521 | High Similarity | NPC251110 |
0.9521 | High Similarity | NPC262623 |
0.9517 | High Similarity | NPC142876 |
0.9517 | High Similarity | NPC333691 |
0.9517 | High Similarity | NPC69430 |
0.9517 | High Similarity | NPC139293 |
0.9517 | High Similarity | NPC200060 |
0.9517 | High Similarity | NPC264550 |
0.9517 | High Similarity | NPC40290 |
0.9517 | High Similarity | NPC195763 |
0.9517 | High Similarity | NPC264289 |
0.9514 | High Similarity | NPC125449 |
0.9514 | High Similarity | NPC188074 |
0.9507 | High Similarity | NPC254659 |
0.9463 | High Similarity | NPC99597 |
0.9463 | High Similarity | NPC210084 |
0.9459 | High Similarity | NPC256612 |
0.9459 | High Similarity | NPC2928 |
0.9459 | High Similarity | NPC134287 |
0.9459 | High Similarity | NPC130589 |
0.9459 | High Similarity | NPC20830 |
0.9456 | High Similarity | NPC120163 |
0.9456 | High Similarity | NPC198826 |
0.9456 | High Similarity | NPC275836 |
0.9456 | High Similarity | NPC212678 |
0.9456 | High Similarity | NPC301323 |
0.9456 | High Similarity | NPC293183 |
0.9456 | High Similarity | NPC162313 |
0.9456 | High Similarity | NPC156222 |
0.9456 | High Similarity | NPC222830 |
0.9456 | High Similarity | NPC239128 |
0.9456 | High Similarity | NPC71334 |
0.9456 | High Similarity | NPC83508 |
0.9456 | High Similarity | NPC188203 |
0.9456 | High Similarity | NPC57030 |
0.9456 | High Similarity | NPC241498 |
0.9456 | High Similarity | NPC131624 |
0.9456 | High Similarity | NPC275722 |
0.9456 | High Similarity | NPC256283 |
0.9456 | High Similarity | NPC187498 |
0.9456 | High Similarity | NPC100887 |
0.9456 | High Similarity | NPC25270 |
0.9452 | High Similarity | NPC179183 |
0.9452 | High Similarity | NPC239363 |
0.9452 | High Similarity | NPC29231 |
0.9452 | High Similarity | NPC61620 |
0.9452 | High Similarity | NPC62042 |
0.9452 | High Similarity | NPC472279 |
0.9452 | High Similarity | NPC248102 |
0.9452 | High Similarity | NPC45873 |
0.9448 | High Similarity | NPC139364 |
0.9448 | High Similarity | NPC254702 |
0.9448 | High Similarity | NPC194653 |
0.9448 | High Similarity | NPC203747 |
0.9448 | High Similarity | NPC80710 |
0.9441 | High Similarity | NPC207732 |
0.9437 | High Similarity | NPC284556 |
0.9437 | High Similarity | NPC312256 |
0.9437 | High Similarity | NPC301178 |
0.9433 | High Similarity | NPC50823 |
0.94 | High Similarity | NPC16935 |
0.9396 | High Similarity | NPC235165 |
0.9396 | High Similarity | NPC255106 |
0.9396 | High Similarity | NPC472916 |
0.9392 | High Similarity | NPC274327 |
0.9392 | High Similarity | NPC183878 |
0.9392 | High Similarity | NPC231018 |
0.9392 | High Similarity | NPC176775 |
0.9392 | High Similarity | NPC47781 |
0.9392 | High Similarity | NPC255350 |
0.9392 | High Similarity | NPC69394 |
0.9392 | High Similarity | NPC22519 |
0.9392 | High Similarity | NPC145379 |
0.9392 | High Similarity | NPC160951 |
0.9388 | High Similarity | NPC117579 |
0.9384 | High Similarity | NPC296197 |
0.9384 | High Similarity | NPC216318 |
0.9384 | High Similarity | NPC259713 |
0.9384 | High Similarity | NPC17286 |
0.9384 | High Similarity | NPC294502 |
0.9384 | High Similarity | NPC200221 |
0.9379 | High Similarity | NPC61871 |
0.9379 | High Similarity | NPC55557 |
0.9379 | High Similarity | NPC30647 |
0.9371 | High Similarity | NPC471417 |
0.9371 | High Similarity | NPC119663 |
0.9366 | High Similarity | NPC110419 |
0.9338 | High Similarity | NPC476980 |
0.9333 | High Similarity | NPC78103 |
0.9333 | High Similarity | NPC474208 |
0.9333 | High Similarity | NPC78225 |
0.9333 | High Similarity | NPC36852 |
0.9333 | High Similarity | NPC222814 |
0.9333 | High Similarity | NPC474836 |
0.9333 | High Similarity | NPC262286 |
0.9333 | High Similarity | NPC96167 |
0.9333 | High Similarity | NPC472910 |
0.9333 | High Similarity | NPC472914 |
0.9333 | High Similarity | NPC245758 |
0.9333 | High Similarity | NPC162869 |
0.9333 | High Similarity | NPC48208 |
0.9333 | High Similarity | NPC472911 |
0.9333 | High Similarity | NPC156057 |
0.9333 | High Similarity | NPC472913 |
0.9333 | High Similarity | NPC475267 |
0.9329 | High Similarity | NPC201136 |
0.9329 | High Similarity | NPC196439 |
0.9329 | High Similarity | NPC4455 |
0.9329 | High Similarity | NPC138360 |
0.9329 | High Similarity | NPC280339 |
0.9329 | High Similarity | NPC201451 |
0.9329 | High Similarity | NPC213622 |
0.9329 | High Similarity | NPC92659 |
0.9329 | High Similarity | NPC227325 |
0.9329 | High Similarity | NPC44079 |
0.9329 | High Similarity | NPC167815 |
0.9329 | High Similarity | NPC26227 |
0.9329 | High Similarity | NPC183597 |
0.9329 | High Similarity | NPC146165 |
0.9329 | High Similarity | NPC163780 |
0.9329 | High Similarity | NPC50715 |
0.9329 | High Similarity | NPC128863 |
0.9329 | High Similarity | NPC2476 |
0.9329 | High Similarity | NPC208197 |
0.9324 | High Similarity | NPC39732 |
0.9324 | High Similarity | NPC142540 |
0.9324 | High Similarity | NPC60972 |
0.932 | High Similarity | NPC184136 |
0.932 | High Similarity | NPC306821 |
0.9315 | High Similarity | NPC196277 |
0.9315 | High Similarity | NPC118726 |
0.9315 | High Similarity | NPC12367 |
0.9315 | High Similarity | NPC276930 |
0.9315 | High Similarity | NPC43669 |
0.9315 | High Similarity | NPC272721 |
0.9315 | High Similarity | NPC194856 |
0.931 | High Similarity | NPC12377 |
0.9306 | High Similarity | NPC242893 |
0.9306 | High Similarity | NPC38065 |
0.9276 | High Similarity | NPC258331 |
0.9276 | High Similarity | NPC188486 |
0.9276 | High Similarity | NPC308992 |
0.9276 | High Similarity | NPC295009 |
0.9276 | High Similarity | NPC260640 |
0.9276 | High Similarity | NPC311740 |
0.9272 | High Similarity | NPC195832 |
0.9272 | High Similarity | NPC196879 |
0.9267 | High Similarity | NPC68093 |
0.9267 | High Similarity | NPC266960 |
0.9267 | High Similarity | NPC49824 |
0.9267 | High Similarity | NPC470762 |
0.9267 | High Similarity | NPC247017 |
0.9267 | High Similarity | NPC191146 |
0.9267 | High Similarity | NPC98661 |
0.9267 | High Similarity | NPC245546 |
0.9267 | High Similarity | NPC43243 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC183655 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9392 | High Similarity | NPD2801 | Approved |
0.9195 | High Similarity | NPD1934 | Approved |
0.9041 | High Similarity | NPD1511 | Approved |
0.9013 | High Similarity | NPD3882 | Suspended |
0.8919 | High Similarity | NPD1512 | Approved |
0.8882 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8865 | High Similarity | NPD1240 | Approved |
0.8865 | High Similarity | NPD943 | Approved |
0.875 | High Similarity | NPD1510 | Phase 2 |
0.8741 | High Similarity | NPD1607 | Approved |
0.8625 | High Similarity | NPD3818 | Discontinued |
0.8616 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8616 | High Similarity | NPD6166 | Phase 2 |
0.8616 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8491 | Intermediate Similarity | NPD6232 | Discontinued |
0.8481 | Intermediate Similarity | NPD5494 | Approved |
0.8462 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8447 | Intermediate Similarity | NPD7473 | Discontinued |
0.8446 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8442 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8408 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8405 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8378 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8378 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8364 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8355 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD7054 | Approved |
0.8313 | Intermediate Similarity | NPD1247 | Approved |
0.8311 | Intermediate Similarity | NPD2935 | Discontinued |
0.8293 | Intermediate Similarity | NPD7472 | Approved |
0.8288 | Intermediate Similarity | NPD230 | Phase 1 |
0.828 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8243 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.82 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.817 | Intermediate Similarity | NPD6799 | Approved |
0.8133 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8125 | Intermediate Similarity | NPD9494 | Approved |
0.8125 | Intermediate Similarity | NPD7075 | Discontinued |
0.8125 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8084 | Intermediate Similarity | NPD7251 | Discontinued |
0.8067 | Intermediate Similarity | NPD2796 | Approved |
0.805 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8041 | Intermediate Similarity | NPD447 | Suspended |
0.8036 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8014 | Intermediate Similarity | NPD3027 | Phase 3 |
0.8013 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD5402 | Approved |
0.7988 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7975 | Intermediate Similarity | NPD6599 | Discontinued |
0.7963 | Intermediate Similarity | NPD919 | Approved |
0.7945 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7937 | Intermediate Similarity | NPD7819 | Suspended |
0.7917 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7881 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7875 | Intermediate Similarity | NPD6801 | Discontinued |
0.7857 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD1613 | Approved |
0.7852 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7847 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7812 | Intermediate Similarity | NPD7411 | Suspended |
0.7792 | Intermediate Similarity | NPD2800 | Approved |
0.7778 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7771 | Intermediate Similarity | NPD2533 | Approved |
0.7771 | Intermediate Similarity | NPD2534 | Approved |
0.7771 | Intermediate Similarity | NPD2532 | Approved |
0.7759 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD3750 | Approved |
0.7692 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7683 | Intermediate Similarity | NPD3749 | Approved |
0.7673 | Intermediate Similarity | NPD920 | Approved |
0.7662 | Intermediate Similarity | NPD2344 | Approved |
0.7661 | Intermediate Similarity | NPD6559 | Discontinued |
0.7651 | Intermediate Similarity | NPD6959 | Discontinued |
0.7632 | Intermediate Similarity | NPD6651 | Approved |
0.7595 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.758 | Intermediate Similarity | NPD6190 | Approved |
0.7564 | Intermediate Similarity | NPD1243 | Approved |
0.7562 | Intermediate Similarity | NPD5403 | Approved |
0.7547 | Intermediate Similarity | NPD5401 | Approved |
0.7547 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.753 | Intermediate Similarity | NPD6234 | Discontinued |
0.7516 | Intermediate Similarity | NPD1653 | Approved |
0.7516 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7515 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7515 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1203 | Approved |
0.75 | Intermediate Similarity | NPD9268 | Approved |
0.7486 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7472 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7469 | Intermediate Similarity | NPD3226 | Approved |
0.7468 | Intermediate Similarity | NPD2309 | Approved |
0.7456 | Intermediate Similarity | NPD5242 | Approved |
0.7452 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7451 | Intermediate Similarity | NPD1933 | Approved |
0.7439 | Intermediate Similarity | NPD37 | Approved |
0.7427 | Intermediate Similarity | NPD3751 | Discontinued |
0.7421 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD2799 | Discontinued |
0.7419 | Intermediate Similarity | NPD3748 | Approved |
0.7399 | Intermediate Similarity | NPD5953 | Discontinued |
0.7384 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7383 | Intermediate Similarity | NPD1470 | Approved |
0.7377 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7375 | Intermediate Similarity | NPD7390 | Discontinued |
0.7375 | Intermediate Similarity | NPD4357 | Discontinued |
0.7368 | Intermediate Similarity | NPD2313 | Discontinued |
0.7361 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7337 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7333 | Intermediate Similarity | NPD2798 | Approved |
0.7325 | Intermediate Similarity | NPD2346 | Discontinued |
0.7305 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7305 | Intermediate Similarity | NPD4965 | Approved |
0.7305 | Intermediate Similarity | NPD228 | Approved |
0.7305 | Intermediate Similarity | NPD4966 | Approved |
0.7297 | Intermediate Similarity | NPD9717 | Approved |
0.7292 | Intermediate Similarity | NPD9493 | Approved |
0.7285 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7273 | Intermediate Similarity | NPD6386 | Approved |
0.7273 | Intermediate Similarity | NPD6385 | Approved |
0.7261 | Intermediate Similarity | NPD6100 | Approved |
0.7261 | Intermediate Similarity | NPD6099 | Approved |
0.7257 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7251 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD5353 | Approved |
0.7233 | Intermediate Similarity | NPD2654 | Approved |
0.723 | Intermediate Similarity | NPD1201 | Approved |
0.723 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7225 | Intermediate Similarity | NPD7228 | Approved |
0.7222 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7193 | Intermediate Similarity | NPD5710 | Approved |
0.7193 | Intermediate Similarity | NPD5711 | Approved |
0.7193 | Intermediate Similarity | NPD3787 | Discontinued |
0.7192 | Intermediate Similarity | NPD9545 | Approved |
0.7189 | Intermediate Similarity | NPD6776 | Approved |
0.7189 | Intermediate Similarity | NPD6777 | Approved |
0.7189 | Intermediate Similarity | NPD6781 | Approved |
0.7189 | Intermediate Similarity | NPD6778 | Approved |
0.7189 | Intermediate Similarity | NPD6782 | Approved |
0.7189 | Intermediate Similarity | NPD6780 | Approved |
0.7189 | Intermediate Similarity | NPD6779 | Approved |
0.7181 | Intermediate Similarity | NPD1608 | Approved |
0.7181 | Intermediate Similarity | NPD3972 | Approved |
0.7179 | Intermediate Similarity | NPD2899 | Discontinued |
0.7143 | Intermediate Similarity | NPD411 | Approved |
0.7133 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7133 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7124 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7119 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7114 | Intermediate Similarity | NPD422 | Phase 1 |
0.7081 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7074 | Intermediate Similarity | NPD7435 | Discontinued |
0.7067 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7056 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7056 | Intermediate Similarity | NPD8150 | Discontinued |
0.7055 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD824 | Approved |
0.7048 | Intermediate Similarity | NPD7458 | Discontinued |
0.7039 | Intermediate Similarity | NPD1164 | Approved |
0.7032 | Intermediate Similarity | NPD3764 | Approved |
0.7024 | Intermediate Similarity | NPD6844 | Discontinued |
0.7013 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7011 | Intermediate Similarity | NPD2403 | Approved |
0.7 | Intermediate Similarity | NPD1471 | Phase 3 |
0.6984 | Remote Similarity | NPD7696 | Phase 3 |
0.6984 | Remote Similarity | NPD7697 | Approved |
0.6984 | Remote Similarity | NPD7698 | Approved |
0.6983 | Remote Similarity | NPD8312 | Approved |
0.6983 | Remote Similarity | NPD8313 | Approved |
0.6981 | Remote Similarity | NPD4308 | Phase 3 |
0.698 | Remote Similarity | NPD17 | Approved |
0.6979 | Remote Similarity | NPD8151 | Discontinued |
0.6974 | Remote Similarity | NPD1876 | Approved |
0.6966 | Remote Similarity | NPD5283 | Phase 1 |
0.6954 | Remote Similarity | NPD1481 | Phase 2 |
0.6947 | Remote Similarity | NPD7870 | Phase 2 |
0.6947 | Remote Similarity | NPD7871 | Phase 2 |
0.6941 | Remote Similarity | NPD2296 | Approved |
0.6937 | Remote Similarity | NPD5408 | Approved |
0.6937 | Remote Similarity | NPD5405 | Approved |
0.6937 | Remote Similarity | NPD5404 | Approved |
0.6937 | Remote Similarity | NPD5406 | Approved |
0.6935 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD2354 | Approved |
0.6931 | Remote Similarity | NPD6823 | Phase 2 |
0.6927 | Remote Similarity | NPD7701 | Phase 2 |
0.6923 | Remote Similarity | NPD3268 | Approved |
0.6923 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6919 | Remote Similarity | NPD6534 | Approved |
0.6919 | Remote Similarity | NPD6535 | Approved |
0.6894 | Remote Similarity | NPD7266 | Discontinued |
0.6887 | Remote Similarity | NPD1535 | Discovery |
PubChem CID   | 3938139 |
ChEMBL   | CHEMBL1613209 |
ZINC   |
Molecular Weight:   | 244.07 |
ALogP:   | -1.2362 |
MLogP:   | 2.56 |
XLogP:   | 3.103 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 66.76 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 18 |